Children living with HIV demonstrate deficits in bone architecture and reductions in bone strength, compared with children without HIV.
All articles by Zahra Masoud
Particular antiretroviral therapy (ART) regimens may decrease bone mass density (BMD) in both adolescents and older people living with HIV (PWHIV).
Alendronate treatment decreases fracture risk in children with other chronic diseases affecting bone; similar long-term outcomes are anticipated in children and adolescents with HIV.
In women with HIV and diabetes mellitus, CD4+ lymphocytes may contribute to the development of diabetes mellitus.
People living with HIV, non-alcoholic fatty liver disease, and antiretroviral-associated lipodystrophy may be at an increased risk of developing type 2 diabetes.
Researchers examined unplanned pregnancies and contraceptive use among HIV-positive women in a cross-sectional study.
In patients with insulin-treated diabetes and sepsis, increased highest glucose levels and glycemic variability have a significant illness severity-adjusted association with decreasing in-hospital mortality.
Latest News Your top articles for MondayFor More Personalized News
Haymarket Medical NetworkTop Picks
Continuing Medical Education (CME/CE) Courses